NCT05609071

Brief Summary

If intracranial pressure can be measured non-invasively using single-channel EEG, clinicians will be able to easily monitor changes in intracranial pressure in patients with brain diseases in the clinical setting. Therefore, a more efficient treatment plan can be established and the prognosis of patients with brain disease can be expected to improve in the long term.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 22, 2022

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 30, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 8, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2023

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

April 20, 2023

Status Verified

April 1, 2023

Enrollment Period

11 months

First QC Date

October 30, 2022

Last Update Submit

April 19, 2023

Conditions

Keywords

ElectroencephalogramIntensive care unitIntracranial pressure monitoring

Outcome Measures

Primary Outcomes (1)

  • Difference between estimated intracranial pressure and actual intracranial pressure

    The difference between the estimated intracranial pressure and the actual intracranial pressure is calculated using the previously developed intracranial pressure prediction formula using quantitative EEG parameters.

    through study completion, an average of 1 year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study is intended for patients admitted to the intensive care unit (ICU) who are adults (18 years or older) and who are undergoing intracranial pressure measurement for some type of brain disease. Except for cases where the 2-channel EEG cannot be attached, it is intended for patients who can acquire EEG.

You may qualify if:

  • Age 18 years or older
  • Patients have had or are planning to insert an intracranial pressure monitoring device due to brain diseases
  • Emergency room or intensive care unit of the study hospital

You may not qualify if:

  • EEG measurement is restricted due to trauma or head deformity
  • The attachment of electrodes for EEG measurement interferes with the standard treatment
  • Patients who do not agree to enroll to this study by patients or caregivers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University HOspital

Seoul, 03080, South Korea

Location

MeSH Terms

Conditions

Intracranial HypertensionBrain Diseases

Condition Hierarchy (Ancestors)

Central Nervous System DiseasesNervous System Diseases

Study Officials

  • Ki Hong Kim

    Seoul National University Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2022

First Posted

November 8, 2022

Study Start

March 22, 2022

Primary Completion

February 28, 2023

Study Completion

December 31, 2024

Last Updated

April 20, 2023

Record last verified: 2023-04

Locations